Supply Chain
Our supply chain begins and ends with the patient. Whether it’s a child managing diabetes in a remote village or an adult undergoing cancer therapy in a major city, we ask: How can we get this therapy to them efficiently, reliably, and affordably?
Built on four key pillars – Patient-centricity, Precise Demand Planning, Supply Resilience and Smart Capital Management. Our supply chain approach reflects a deep commitment to delivering life-changing therapies to those who need them the most, with speed, reliability, and responsibility.
Furthermore, every element of Biocon Biologics global supply network is devised with one goal: delivering the right-quality medication to patients on time, with minimal wastage, while creating a Sustainable Social Impact
This integrated approach ensures that scientific breakthroughs don’t stop at the lab or manufacturing floor but travel the last mile, making equitable and sustainable access to life-saving biologics a global reality.
Patient-Centricity in Supply Chain
Every decision we make begins with a simple question: How does this impact the patient?
Our global network is designed to be agile, integrating real-time data across manufacturing sites, and logistics platforms.
This responsiveness allows us to anticipate patient needs, from urban centres in advanced markets to underserved communities in emerging geographies.
Resilient Supply and Social Impact
We see our supply chain as a vehicle for global health equity.
From pandemic-era disruptions to complex geopolitical landscapes, we ensure continuity of supply through robust infrastructure, strategic partnerships, and humanitarian distribution models.
Our supply chain resilience comes from four key aspects: Planning for redundancies, setting up multiple vendors, geographical diversification and preparedness for responding to emergencies. Our goal is to ensure every patient who needs our life savings medicines, receives them on time, every time.
Precise Demand Planning
Our demand forecasting leverages granular analytics by product and geography.
Coupled with seamless alignment with commercial teams, which enables us to reduce bias, minimize waste, and improve product availability, thus delivering the right therapy, at the right time, in the right place for patients
Smart Capital Management
With disciplined planning, lean inventory systems, and optimized working capital, we are building a cost-efficient supply model that supports reinvestment in innovation and access, ensuring that life-changing discoveries are created and delivered to patients world-over.
Our growing network of internal and external manufacturing partners spans India, Malaysia, and now includes footprints in the US and Europe—enabling us to scale with purpose and serve patients globally.
Anchored in Sustainability and Partnership
We embed environmental, social, and governance (ESG) principles deep into our sourcing and distribution practices and ensure that this responsibility also extends to our suppliers, contract manufacturing organizations (CMOs), distributors and other business partners.
Through initiatives like our Business Partner Code of Conduct we ensure that our partners diligently implement the principles and aspirations of the Company across ESG considerations, within their operations and improve their own ESG journey.
Through our annual Global Supplier Conclave we collaborate with over 100 partners to create a more resilient and responsible supply ecosystem.
